tiprankstipranks
Trending News
More News >
Acro Biomedical Co Ltd (ACBM)
OTHER OTC:ACBM
US Market

Acro Biomedical Co (ACBM) Financial Statements

Compare
11 Followers

Acro Biomedical Co Financial Overview

Acro Biomedical Co's market cap is currently $1.33M. The company's EPS TTM is $; its P/E ratio is -12.94; Acro Biomedical Co is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 658.50K$ 1.20M
Gross Profit$ 0.00$ 0.00$ 0.00$ 140.50K$ 259.50K
Operating Income$ -154.02K$ -37.96K$ -8.80M$ -15.87M$ -7.69M
EBITDA$ -154.02K$ -37.96K$ 0.00$ -15.87M$ 0.00
Net Income$ -101.15K$ -42.30K$ -8.81M$ -15.87M$ -7.70M
Balance Sheet
Cash & Short-Term Investments$ 4.10K$ 476.00$ 376.00$ 5.85K$ 95.25K
Total Assets$ 14.10K$ 31.97K$ 58.46K$ 687.49K$ 761.08K
Total Debt$ 325.51K$ 26.90K$ 52.23K$ 25.72K$ 50.43K
Net Debt$ 321.41K$ 26.42K$ 51.86K$ 19.87K$ -44.82K
Total Liabilities$ 401.06K$ 326.95K$ 315.47K$ 201.12K$ 117.37K
Stockholders' Equity$ -386.96K$ -294.97K$ -257.01K$ 486.37K$ 643.71K
Cash Flow
Free Cash Flow$ -196.30K$ -36.69K$ -15.45K$ -147.48K$ 299.33K
Operating Cash Flow$ -196.30K$ -36.69K$ -15.45K$ -147.48K$ 299.33K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 199.92K$ 36.79K$ 9.97K$ 58.09K$ -222.21K
Currency in USD

Acro Biomedical Co Earnings and Revenue History

Acro Biomedical Co Debt to Assets

Acro Biomedical Co Cash Flow

Acro Biomedical Co Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.